New York State Common Retirement Fund’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-71,900
| Closed | -$1.29M | – | 3259 |
|
|
2020
Q2 | $1.29M | Sell |
71,900
-403,345
| -85% | -$5.61M | ﹤0.01% | 1738 |
|
|
2020
Q1 | $3.39M | Buy |
475,245
+51,239
| +12% | +$639K | 0.01% | 1204 |
|
|
2019
Q4 | $10.1M | Sell |
424,006
-4,900
| -1% | -$135K | 0.01% | 957 |
|
|
2019
Q3 | $11.5M | Buy |
428,906
+95,491
| +29% | +$2.68M | 0.01% | 890 |
|
|
2019
Q2 | $9.05M | Buy |
333,415
+3,800
| +1% | +$119K | 0.01% | 1017 |
|
|
2019
Q1 | $11.4M | Buy |
329,615
+263,815
| +401% | +$7.61M | 0.01% | 905 |
|
|
2018
Q4 | $1.28M | Sell |
65,800
-6,700
| -9% | -$138K | ﹤0.01% | 1767 |
|
|
2018
Q3 | $1.93M | Sell |
72,500
-6,121
| -8% | -$200K | ﹤0.01% | 1701 |
|
|
2018
Q2 | $2.97M | Buy |
78,621
+13,185
| +20% | +$504K | ﹤0.01% | 1480 |
|
|
2018
Q1 | $2.14M | Sell |
65,436
-4,911
| -7% | -$216K | ﹤0.01% | 1587 |
|
|
2017
Q4 | $3.42M | Buy |
70,347
+10,167
| +17% | +$514K | ﹤0.01% | 1385 |
|
|
2017
Q3 | $3.25M | Sell |
60,180
-9,606
| -14% | -$564K | ﹤0.01% | 1395 |
|
|
2017
Q2 | $3.92M | Sell |
69,786
-5,036
| -7% | -$202K | 0.01% | 1373 |
|
|
2017
Q1 | $2.93M | Buy |
74,822
+24,622
| +49% | +$784K | ﹤0.01% | 1475 |
|
|
2016
Q4 | $1.13M | Hold |
50,200
| – | – | ﹤0.01% | 1978 |
|
|
2016
Q3 | $1.14M | Sell |
50,200
-3,688
| -7% | -$86.6K | ﹤0.01% | 1939 |
|
|
2016
Q2 | $1.27M | Buy |
53,888
+228
| +0.4% | +$5.63K | ﹤0.01% | 1842 |
|
|
2016
Q1 | $1.09M | Sell |
53,660
-14,463
| -21% | -$459K | ﹤0.01% | 1896 |
|
|
2015
Q4 | $3.5M | Buy |
68,123
+2,376
| +4% | +$115K | 0.01% | 1372 |
|
|
2015
Q3 | $2.8M | Buy |
65,747
+12,948
| +25% | +$625K | ﹤0.01% | 1447 |
|
|
2015
Q2 | $2.4M | Buy |
52,799
+48,956
| +1,274% | +$1.97M | ﹤0.01% | 1764 |
|
|
2015
Q1 | $146K | Buy |
+3,843
| New | +$132K | ﹤0.01% | 2190 |
|
New York State Common Retirement Fund's PTLA Position: Q3 2020 in Review
New York State Common Retirement Fund sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 71,900 shares — an estimated $1.29M sold.
New York State Common Retirement Fund first reported a position in PTLA in Q1 2015 and held it in 22 quarters. The position peaked at $11.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- New York State Common Retirement Fund reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 71,900 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.29M.
- New York State Common Retirement Fund first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 22 quarters.
- New York State Common Retirement Fund's Portola Pharmaceuticals, Inc. position peaked at $11.5M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on New York State Common Retirement Fund's 13F filing for Q3 2020, filed 5 Nov 2020.